Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2025International Journal of Innovative Technologies in Social ScienceOpen Access

Innovations in Obesity Treatment – GLP – 1 Pharmacotherapy and Bariatric Surgery

View Full Paper
Ask AI
Bookmark
Share

Authors

PBPiotr BartnikJPJan PalmiEBElżbieta Bebrysz

Discussion

Loading...

Member takes

Overview

Comparative analysis highlights GLP-1 receptor agonists and bariatric surgery's effectiveness in obesity treatment.

Key Points

  • Both glp-1 receptor agonists and metabolic surgery effectively reduce body weight in obesity treatment.
  • GLP-1 therapy led to moderate weight loss of 5-15%, improving metabolic health in patients.
  • Bariatric surgery resulted in greater weight loss of 25-35% and significant improvements in type 2 diabetes.
  • Surgical interventions increase glp-1 levels, suggesting potential hormonal mechanisms enhancing effectiveness.

Cite This Study

Bartnik et al. (2025) studied this question.

synapsesocial.com/papers/68d43d83713b0b5dfea7df02https://doi.org/10.31435/ijitss.3(47).2025.3682
View Full Paper
Ask AI
Bookmark
Share